DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 178 filers reported holding DEPOMED INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,166,000 | +19.3% | 324,663 | +17.9% | 0.44% | +15.1% |
| Q1 2018 | $1,815,000 | +275.8% | 275,448 | +359.4% | 0.38% | +184.4% |
| Q4 2017 | $483,000 | +100.4% | 59,953 | +44.0% | 0.14% | +95.7% |
| Q3 2017 | $241,000 | -46.1% | 41,631 | 0.0% | 0.07% | -37.3% |
| Q2 2017 | $447,000 | -14.4% | 41,631 | 0.0% | 0.11% | -11.3% |
| Q1 2017 | $522,000 | +397.1% | 41,631 | +614.0% | 0.12% | +376.9% |
| Q4 2016 | $105,000 | -28.1% | 5,831 | 0.0% | 0.03% | -27.8% |
| Q3 2016 | $146,000 | +28.1% | 5,831 | 0.0% | 0.04% | +16.1% |
| Q2 2016 | $114,000 | +40.7% | 5,831 | 0.0% | 0.03% | +40.9% |
| Q1 2016 | $81,000 | +8000.0% | 5,831 | +13460.5% | 0.02% | – |
| Q1 2015 | $1,000 | 0.0% | 43 | -38.6% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 70 | -16.7% | 0.00% | – |
| Q3 2014 | $1,000 | -100.0% | 84 | -100.0% | 0.00% | -100.0% |
| Q2 2014 | $2,497,000 | +53.8% | 179,700 | +60.4% | 0.27% | +46.2% |
| Q1 2014 | $1,624,000 | +40.6% | 112,023 | -27.6% | 0.19% | +25.7% |
| Q3 2013 | $1,155,000 | – | 154,655 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DELTEC ASSET MANAGEMENT LLC | 1,876,195 | $42,045,000 | 9.16% |
| Senvest Management, LLC | 3,331,531 | $74,660,000 | 4.62% |
| Krensavage Asset Management, LLC | 343,546 | $7,699,000 | 3.51% |
| PERKINS CAPITAL MANAGEMENT INC | 97,950 | $2,195,000 | 1.84% |
| HAYS ADVISORY LLC | 580,069 | $12,999,000 | 1.68% |
| ARBOR CAPITAL MANAGEMENT LLC | 572,200 | $12,823,000 | 1.54% |
| Broadfin Capital, LLC | 705,204 | $15,804,000 | 1.23% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 556,311 | $13,969,000 | 1.14% |
| Pier Capital, LLC | 330,682 | $7,411,000 | 1.12% |
| TURNER INVESTMENTS LLC | 259,357 | $5,812,000 | 1.04% |